1224945-45-2

Basic information

• Product Name: tert-butyl (S)-2-(2-bromophenyl)pyrrolidine-1-carboxylate
• Synonyms: tert-butyl (S)-2-(2-bromophenyl)pyrrolidine-1-carboxylate
• CAS NO: 1224945-45-2
• Molecular Weight: 326.233
• Mol File: 1224945-45-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: tert-butyl (S)-2-(2-bromophenyl)pyrrolidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (S)-2-(2-bromophenyl)pyrrolidine-1-carboxylate(1224945-45-2)
• EPA Substance Registry System: tert-butyl (S)-2-(2-bromophenyl)pyrrolidine-1-carboxylate(1224945-45-2)

Safety Data

• Hazardous Substances Data: 1224945-45-2(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 129540-24-5 2-(2-bromophenyl)pyrrolidine 

Downstream Products

• 1224945-50-9 (S)-tert-butyl 2-(2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenyl)pyrrolidine-1-carboxylate 

Relevant articles and documents

1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES

The present invention relates to lH-pyrrolo[2,3-b]pyridine derivatives and related compounds as BCL-2 inhibitors for treating neoplastic, autoimmune or neurodegenerative diseases. The present description discloses the synthesis and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 162 to 233; examples 1 to 8; table; compound examples cpd-1 to cpd-135; biological examples 1 to 4).

( PYRROLIDIN-2 -YL) PHENYL DERIVATIVES FOR USE IN THE TREATMENT OF PAIN

The invention relates to (pyrrolidin-2-yl)phenyl derivatives having the general Formula (I), wherein R1 is (C1-4)alkyl, halo(C1-4)alkyl, (C1-4)alkyloxy, or halo(C1-4)alkyloxy; R2 is H, (Cs